#Neonatal Seizures Drugs Market Size

[digimarketresearch]

Neonatal Seizures Drugs Market Size, Share, Trends, Global Demand, Growth and Opportunity Analysis

"Data Bridge Market research has recently issued comprehensive industry research on Global Neonatal Seizures Drugs Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. The market insights gained through this Neonatal Seizures Drugs market research analysis report facilitates more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently.

An analysis of competitors is conducted very well in the reliable Neonatal Seizures Drugs Market report which covers vital market aspects about the key players. Moreover, the report gives out market potential for many regions across the globe based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios. It gives significant information and data pertaining to their insights in terms of finances, product portfolios, investment plans, and marketing and business strategies. Detailed market analysis has been performed here with the inputs from industry experts.

Access Full 350 Pages PDF Report @

Data Bridge Market Research analyses that the neonatal seizures drugs? market was valued at USD 222.5 million in 2021 and is expected to reach USD 290.73 million by 2029, registering a CAGR of 3.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Neonatal Seizures Drugs Market

Chapter 3: Regional analysis of the Global Neonatal Seizures Drugs Market industry

Chapter 4: Neonatal Seizures Drugs Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Key Questions Answered with this Study

1) What makes Neonatal Seizures Drugs Market feasible for long term investment?

2) Know value chain areas where players can create value?

3) Teritorry that may see steep rise in CAGR & Y-O-Y growth?

4) What geographic region would have better demand for product/services?

5) What opportunity emerging territory would offer to established and new entrants in Neonatal Seizures Drugs Market?

6) Risk side analysis connected with service providers?

7) How influencing factors driving the demand of Neonatal Seizures Drugsin next few years?

8) What is the impact analysis of various factors in the Global Neonatal Seizures Drugs Market growth?

9) What strategies of big players help them acquire share in mature market?

10) How Technology and Customer-Centric Innovation is bringing big Change in Neonatal Seizures Drugs Market?

Some of the major players operating in the neonatal seizures drugs? market are:

Merck KGaA (Germany)

Eisai Co., Ltd. (Japan)

AstraZeneca (UK)

Sanofi (France)

Novartis AG (Switzerland)

Abbott (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Teva Pharmaceutical Industries Ltd. (Ireland)

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

WOCKHARDT (Mumbai)

Novo Nordisk A/S (Denmark)

Glenmark Pharmaceuticals Limited (India)

Cipla Inc. (US)

Bausch Health Companies Inc. (Canada)

Otsuka America Pharmaceutical, Inc. (US)

Johnson & Johnson Private Limited (US)

Takeda Pharmaceutical Company Limited (Japan)

Sumitomo Corporation (Japan)

Biocon (India)

Browse Trending Reports:

Medical Tuning Fork Market

North America Cbct Dental Imaging Market

Myopia Treatment Market

Induced Pluripotent Stem Cells Market

Pneumococcal Vaccine Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com"

[aimarketresearch]

Neonatal Seizures Drugs Market Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook

Data Bridge Market research has recently issued comprehensive industry research on Global Neonatal Seizures Drugs Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. The market insights gained through this Neonatal Seizures Drugs market research analysis report facilitates more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently.

An analysis of competitors is conducted very well in the reliable Neonatal Seizures Drugs Market report which covers vital market aspects about the key players. Moreover, the report gives out market potential for many regions across the globe based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios. It gives significant information and data pertaining to their insights in terms of finances, product portfolios, investment plans, and marketing and business strategies. Detailed market analysis has been performed here with the inputs from industry experts.

Access Full 350 Pages PDF Report @

Data Bridge Market Research analyses that the neonatal seizures drugs? market was valued at USD 222.5 million in 2021 and is expected to reach USD 290.73 million by 2029, registering a CAGR of 3.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Neonatal Seizures Drugs Market

Chapter 3: Regional analysis of the Global Neonatal Seizures Drugs Market industry

Chapter 4: Neonatal Seizures Drugs Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Key Questions Answered with this Study

1) What makes Neonatal Seizures Drugs Market feasible for long term investment?

2) Know value chain areas where players can create value?

3) Teritorry that may see steep rise in CAGR & Y-O-Y growth?

4) What geographic region would have better demand for product/services?

5) What opportunity emerging territory would offer to established and new entrants in Neonatal Seizures Drugs Market?

6) Risk side analysis connected with service providers?

7) How influencing factors driving the demand of Neonatal Seizures Drugsin next few years?

8) What is the impact analysis of various factors in the Global Neonatal Seizures Drugs Market growth?

9) What strategies of big players help them acquire share in mature market?

10) How Technology and Customer-Centric Innovation is bringing big Change in Neonatal Seizures Drugs Market?

Some of the major players operating in the neonatal seizures drugs? market are:

Merck KGaA (Germany)

Eisai Co., Ltd. (Japan)

AstraZeneca (UK)

Sanofi (France)

Novartis AG (Switzerland)

Abbott (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Teva Pharmaceutical Industries Ltd. (Ireland)

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

WOCKHARDT (Mumbai)

Novo Nordisk A/S (Denmark)

Glenmark Pharmaceuticals Limited (India)

Cipla Inc. (US)

Bausch Health Companies Inc. (Canada)

Otsuka America Pharmaceutical, Inc. (US)

Johnson & Johnson Private Limited (US)

Takeda Pharmaceutical Company Limited (Japan)

Sumitomo Corporation (Japan)

Biocon (India)

Browse Trending Reports:

Becker Muscular Dystrophy Treatment Market

North America Mild Cognitive Impairment Mci Treatment Market

Anthrax Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[clevertimetravelpaper]

Microcephaly Market Key Players, Size, Growth, Demand, Development Share, Analysis and Forecast

Microcephaly is the rare neurological disorder in which neonates born with small head or head stop growing after birth as compared to the normal neonates or babies. Microcephaly can be present at birth time (congenital) or may develop after the birth (acquired). Moreover, babies born with microcephaly may also suffer from seizures, learning disabilities as they grow older. There is no cure or treatment for the microcephaly but required medical specialties for many disorders such as pediatrics, infectious diseases, neurology, ophthalmology, genetics and psychology.

 Data Bridge Market Research analyses a growth rate in the global microcephaly market in the forecast period 2022-2029. The expected CAGR of global microcephaly market is tend to be around 8.50% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample PDF of the Report:-    https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microcephaly-market

Key players operating in the global microcephaly market include:

Merck KGaA (Germany)

Novartis AG (Switzerland)

Beckman Coulter Inc. (U.S.)

bioMerieux (France)

Bio-Rad Laboratories, Inc (U.S.)

Danaher (U.S.)

Hologic (U.S.)

Inovio Pharmaceuticals (U.S.)

Lonza (Switzerland)

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

The global microcephaly market is expected to witness significant growth during the forecast period. Rising incidences of neurological disabilities during pregnancy and constant WHO monitoring on countries affected by Zika virus will boost up the microcephaly market. The microcephaly market is majorly driven by rise in prevalence of neurological abnormalities and high diagnostics rate. COVID-19 also had a major impact on the market growth.

To Learn More About Market Analysis, Explore Research Report Summary @:-    https://www.databridgemarketresearch.com/reports/global-microcephaly-market

Scope of the global microcephaly market and market size

The microcephaly market is segmented based on diagnosis, treatment, end-users, and distribution channel.

Based on diagnosis, the microcephaly market is segmented into ultrasound, CT, MRI, and others.

Based on the treatment, the microcephaly market is segmented into drugs, occupational therapy, physical therapy, and others. Medications include anticonvulsants, antiinfectives, and others.

On the basis of end-users, the microcephaly market is segmented into hospitals, specialty clinics, and others.

On the basis of distribution channel, the microcephaly market has also been segmented into Hospital Pharmacy, Retail Pharmacy, Other

Country-Level Analysis of the Microcephaly Market

The global microcephaly market is analysed and market size insights and trends are provided by diagnosis, treatment, distribution channel and end-user as referenced above. The major countries covered in the global microcephaly market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has the largest market share due to the increasing prevalence of neonatal neurological disorders. Asia-Pacific is expected to account for the largest market share in the coming years for the microcephaly market due to increasing WHO and government awareness programs and rising Zika virus infection in Asian countries .

Explore Full TOC At:-   https://www.databridgemarketresearch.com/toc/?dbmr=global-microcephaly-market

The country section of the report also provides individual market impact factors and national market regulatory changes that affect current and future market trends. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import and export tariffs are some of the main metrics used to forecast the market scenario for each country. In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of sales channels are considered by providing forecast analysis of national data.

Top Health Care Report Links:-

https://www.databridgemarketresearch.com/reports/global-purine-analogs-drugs-market

About the Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to discovering the best market opportunities and providing effective information so that your business thrives in the market. Data Bridge strives to provide the right solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a body of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research  has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge knows how to create satisfied customers who trust our services and trust our hard work for sure. We are satisfied with our 99.9% customer satisfaction rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

United Kingdom: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: –   corporatesales@databridgemarketresearch.com

[researchupdates]

Global Neonatal Seizures Drugs Market Growth Statistics to Make Multi-Billion Dollar Market during 2021-2028

Global Neonatal Seizures Drugs Market Synopsis:

The large scale Neonatal Seizures Drugs Market report sheds light on each region, Market size in terms of (USD Mn) for every individual segment and their sub-segment for the period from 2021 to 2027, considering the macro and micro situation factors. The document gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the Market and comprising key regions. Additionally, the wide ranging Neonatal Seizures Drugs Market report helps the manufacturer in finding out the effectiveness of the existing channels of distribution, advertising programmes or media, selling methods and the best way of distributing the goods to the eventual consumers.

An extensive summary of the Neonatal Seizures Drugs Market comprises prominent Market that includes several major Market leaders in the report. Neonatal Seizures Drugs report provides guidelines about planning of advertising and sales promotion efforts. The business document necessitates an in-depth analysis pertaining to the product manufactured by the vendors combining with the product application range. The competitive landscape section of the report gives a clear insight into the Market share analysis of key industry players. Neonatal Seizures Drugs Market report consists of Market attractiveness analysis, wherein each segment is benchmarked based on its Market size, growth rate, and general attractiveness.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neonatal-seizures-drugs-market .

The Global Neonatal Seizures Drugs Market is expected to gain market growth in the forecast period of 2020 to 2027.

According to the market report analysis, Neonatal Convulsions are seizures that occur in babies younger than 4 weeks. Neonatal seizures are epileptic fits that occur from birth to the neonatal phase ending. For all periods of life, it is the most vulnerable condition particularly from the first 1-2 days or week from birth.

The most significant key factors driving the growth of the Global Neonatal Seizures Drugs Market are growing prevalence of the genetic disorders such as fits, consumption of high blood pressure medicines, oestrogen and NSAIDs and the prevalence of chronic diseases such as diabetes, thyroid, kidney disease, damaged or damaging veins and calcium, vitamin deficiency.

The major players covered in the Neonatal Seizures Drugs Market are epilepsy drugs market include UCB Pharma Ltd., Sanofi S.A, Valeant Pharmaceuticals International, Inc., Pfizer, Inc., Johnson & Johnson Services, Inc., Eisai Co., Ltd., Abbott Laboratories, Inc., Novartis AG, GlaxoSmithKline plc, Sunovion Pharmaceuticals, Inc., and Cephalon, Inc. among other domestic and global players.

Regional analysis, North America accounts for the largest market share due to the presence of the product’s primary manufacturers, high spending on research and development and health care, and qualified professionals. Owing to the growing prevalence of thyroid, kidney and liver disorders and the number of generic medications, APAC is projected to account for the largest market share for the neonatal seizures drugs market in coming years.

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-neonatal-seizures-drugs-market .

[opioidjusticeteam]

Oxycontin Birth Defects Lawsuit

Oxycontin Birth Defects Lawsuit

Oxycontin birth defects lawsuit offers hope to mothers of NAS babies

An Oxycontin birth defects lawsuit has offered mothers like Colorado’s Shelly Whittaker something that’s been hard to find over a dozen years of struggling with the ups and downs of raising three sons born with the condition caused by opioid exposure in the womb known as NAS: Hope.

Her doctors never told Whittaker – who began taking OxyContin, the Purdue Pharma-manufactured opioid painkiller, for lupus and rheumatoid arthritis in 2007, after her daughter was born and before she became pregnant with her first son – about the increased risk of birth defects.

And no one mentioned Neonatal Abstinence Syndrome, or NAS, when the boy was born with symptoms such as high-pitched crying, tremors and convulsions, diarrhea, vomiting, and difficulty swallowing. “We took him to the doctor, and I said, ‘I don’t know what’s wrong,’” Whittaker recalled. “They said, ‘He’s fine – we don’t know what it is.’”

But things weren’t fine. Her second son experienced many of the same difficulties at birth, and so did a third son – even though by then there was growing awareness of the addictive nature of Oxycontin and Whittaker had been placed on a different medication, Subutex. As Whittaker, now 38, watches her three sons grow, the boys continue to experience developmental and behavioral problems, and have trouble keeping up in school.

Last year, Whittaker read on social media about an Oxycontin birth defects lawsuit, and she decided to sign on as a plaintiff. She sees legal action against the maker of OxyContin, Purdue Pharma, and other leading drugmakers and distributors as a way to get help for struggling families — as well as some manner of justice.

Like other mothers of children with NAS, Whittaker said there’s a whole array of unmet needs for these kids. “I would love for them to have some help with their schooling,” she said. “There’s no school in my community that helps children who’ve been falling behind.”

NAS babies are a hidden crisis in America

Shelly Whittaker is hardly alone. Our team of lawyers is representing hundreds of mothers like her in the OxyContin birth defects lawsuit that is currently pending. In researching the case, we’ve come to discover that there are literally hundreds of thousands of NAS babies growing up in America – far more than the government has acknowledged. These children and their families need medical help, other assistance, and better information.

Here’s the background: OxyContin and other opioid painkillers were introduced into the U.S. market in the 1990s by big pharmaceutical companies and aggressively marketed to doctors as a cure-all for the pain caused by numerous ailments. Unbeknownst to the American public, these large drugmakers learned fairly quickly that their new medications were highly addictive – warnings that were ignored in the face of billions of dollars in profits.

The result has been the largest drug-addiction crisis in the history of this country. Much of the opioid-abuse epidemic began with medications that were legally prescribed such as OxyContin, Percocet, and Vicodin, although over time many users moved into illegal street drugs such as heroin and fentanyl (which is also sometimes prescribed). Although opioid use peaked around 2012, the latest government statistics still find 58 opioid prescriptions for every 100 citizens. The toll has been enormous. According to the U.S. Centers for Disease Control and Prevention, there were 47,600 overdose deaths related to opioids in America during 2017, the last year for which records were available. That’s nearly as many Americans who died in the entirety of the Vietnam War.

The opioid crisis has become front-page news in many American cities, but information about mothers who used opioids during their pregnancies and their babies has lagged. Unfortunately, America’s doctors were slow to make what today seems like a strong connection between opioid exposure in the womb and birth defects such as club foot, spina bifida, heart defects, cleft palate, hydrocephalus, esophageal atresia, gastroschisis, anorectal atresia, or diaphragmatic hernia.

That’s in addition to the most common adverse outcome: NAS, which causes symptoms such as body shakes, excessive crying or yawns, feeding problems, diarrhea, sleeping problems, fever, or runny noses. As these children grow, many experience behavioral problems, cognitive delays, mental or motor deficits, or attention-deficit disorder (ADD).

The number of American children – and families – affected had been grossly undercounted. The current working government number of about 29,500 NAS births in 2018 falls far short of the real total. Based on information that about one-in-three pregnant women in America — or roughly 1.3 million out of the 3.8 million women who gave birth — were given a prescription for opioid painkillers, our team has estimated that a baby with serious problems related to opioid exposure is born somewhere in the United States every 19 minutes.

A conservative estimate is that this results in roughly 250,000 births every year of children with some level of NAS that will require the type of specialized treatment that we are seeking. That’s more than eight times the government’s figure.

‘None of this is my fault’

One of the hundreds of thousands of American parents who knows the trauma of raising a child exposed to opioids in the womb is Jennifer Scully, a 42-year-old career nurse who lives in upstate New York.

Scully says she’s gotten used to the phone calls from the school attended by her 5-year-old daughter from teachers and staff who don’t understand the seizures occasionally experienced by her child, in which she would stare blankly into space for a minute or two, unresponsive to adults. To Scully, the seizures are one more problem – on top of her small size, limited vocabulary, and delayed potty training – that she connects with opioid exposure.

“Because I’m a nurse, I pay a lot more attention to things,” she says. But the career health-care professional trusted her doctors in 2014 when she unexpectedly became pregnant while under treatment for both the aftermath of a broken back and breast cancer, which is why she was on a drug regimen that included OxyContin.

“They said, ‘We’re not taking you off and besides, it won’t affect the baby,” Scully recalls. Instead, her newborn daughter spent five days in the hospital coping with the symptoms of NAS, including tremors and high-pitched crying. When they finally left the hospital, doctors insisted the worst that Scully would have to deal with would be an occasionally cranky baby – a gross underestimation of the developmental problems her daughter has faced.

Like Whittaker, Scully joined the OxyContin birth defects lawsuit shortly after she read about it on social media. She said she agree with the ambitious goals of the legal action: Long-term health care and a medical monitoring fund for children exposed to opioids in the womb. She says the big pharmaceutical firms “need to be held responsible for what they’ve done. I expected a healthy child. None of this is my fault.”

The legal fight for opioid justice

Over the course of 2019, a series of class-action lawsuits were filed on behalf of opioid-exposed children in a number of states. Our legal team has been working hard to get children born to prescription opioid-dependent-and-using mothers recognized as their own legal class within the national opioid litigation, which is currently before U.S. District Court Judge Daniel A. Polster in Cleveland.

Our efforts are linked closely to the ongoing complex negotiations – involving big pharmaceutical companies and a number of states and localities hoping to recover their costs for dealing with the opioid crisis – aimed at a comprehensive settlement. Late in 2019, the OxyContin manufacturer at the center of the crisis, Purdue Pharma, filed for bankruptcy and floated a tentative settlement of its liability in the range of $10-12 billion.

Our lawyers have argued that the proposed Purdue Pharma deal doesn’t go far enough, and that it allows the founders and largest owners of the firm, the Sackler family, to keep too much of their wealth. But our biggest concern about both the Purdue Pharma deal and the related, more universal settlement talks is that those most in need – hundreds of thousands of kids whose childhood has been disrupted – will get shut out.

Most of our attorneys are very familiar with the landmark settlement in the late 1990s with Big Tobacco, in which the major cigarette makers coughed up millions of dollars that were largely paid out to a coalition of states and other localities — similar to today’s opioid talks. Most of these cash-strapped government entities merely absorbed the money into their general budgets. Very few dollars went toward smoking-cessation programs, or toward the massive health problems that have been caused by smoking.

On behalf of Shelly Whittaker, Jennifer Scully and the thousands of other families stung by the opioid crisis, we desperately want things to be different this time around. The money we are seeking on behalf of the kids, as part of any comprehensive settlement with Big Pharma, would go toward meeting their extensive long-term needs. That includes the medical monitoring fund and collecting data helping doctors understand the scope of the problem and best practices.

The good news is that there is still time for new plaintiffs to join our OxyContin birth defects lawsuit, but that time is also growing short. If your child was exposed to opioid painkillers during pregnancy, join us and our fight for a settlement that will actually benefit families and the communities where they live. Too many parents have suffered in silence for too long. We are fighting for justice and a better future, and we would like you to be part of it.

The post Oxycontin Birth Defects Lawsuit appeared first on Opioid Justice Team.

from Opioid Justice Team https://opioidjusticeteam.com/oxycontin-birth-defects-lawsuit/

[rohinic123-blog]

Pediatric Medical Devices Market  Projected to Witness Vigorous Expansion by 2026

Transparency Market Research (TMR) has published a new report titled, “Pediatric Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and others drive the global market. Moreover, surge in demand for self-care devices/solutions, increase in incidence of chronic and infectious diseases among pediatric population, and technological developments are expected to propel demand for pediatric medical devices used to treat chronic conditions.

Rise in Chronic Conditions to Augment Market

Prevalence of chronic health disorders is rising among children. A report published by the Pediatric Academic Societies in 2016 stated that these chronic conditions are most common among children who live in or near poverty. The report found substantial increase in attention deficit hyperactivity disorder (ADHD) and asthma among children living in poverty, as compared to their comfortable counterparts.

Request For Covid19 Impact Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=46284

The global pediatric medical devices market has been segmented based on product and end-user. In terms of product, the global market has been categorized into in vitro diagnostic (IVD) devices, cardiology devices diagnostic imaging devices, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine, and home-use medical devices. In vitro diagnostic (IVD) devices are available in the form of reagents, kits, instruments, equipment, apparatuses, or systems, used either alone or in combination with other diagnostic tools to gain critical information for health and drug/therapy monitoring. In vitro diagnostics deliver valuable information about the pathological and/or physiological state of the body and, therefore, are essential to make well-informed medical decisions.

Cardiology devices are used to diagnose and monitor patients suffering from cardiovascular diseases, primarily to identify the seriousness of the condition and effect of treatment on a patient. Diagnostic imaging devices are used in the diagnosis of various critical diseases and disorders of vital organs such as liver, lungs, heart, and brain. Usage of diagnostic imaging techniques such as MRI, X-ray, and CT scan has increased in the last two decades. These imaging technologies are painless and offer rapid diagnosis, making them a popular option for patients and doctors alike. Anesthesia devices comprise anesthesia workstations, anesthesia ventilators, anesthesia monitors, and anesthesia delivery machines. Respiratory care devices are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation, and aid mucus removal from bronchi during respiratory therapy.

Planning To Lay Down Future Strategy? Request Brochure Of Pediatric Medical Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46284

Moreover, neonates admitted to neonatal intensive care units are premature, have low birth weight, or suffer from a medical condition that requires special care. Newborns with medical conditions such as infections, birth defects, or heart problems are also cared for in the NICU. Neonatal intensive care units comprise advanced technology and trained health care professionals who provide personal medical attention to the admitted newborn babies. Monitoring devices are used for continuous monitoring of health status of pediatrics by communication techniques, wearable detecting devices, and a small energy consumption microchip with high efficiency data handling algorithms.

Telemedicine includes teleconsultation, telemonitoring, tele-education, teletraining, telecare, and telesurgery. It involves consultation services offered by experienced individuals covering various domains and activities to help, advice, and assist in the overall progress of an activity/initiative. A home-use medical device is proposed for users in any environment outside of a professional health care facility. This comprises devices proposed for use in both professional health care facilities and homes.

Neonatal ICU Devices to Account for Major Market Share

The report offers detailed segmentation of the global pediatric medical devices market based on products and end-user. In terms of product, the neonatal ICU devices segment is estimated to account for major share of the market from 2018 to 2026. The segment is likely to account for the major share of the market by 2026. It is also expected to grow at a rapid pace during the forecast period. Growth of the segment is attributed to increase in number of premature births across the globe.

To Obtain All-Inclusive Information On Forecast Analysis Of Pediatric Medical Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=46284

North America Dominated the Market

North America accounts for the leading share of the global pediatric medical devices market, primarily due to its large patient population and increase in disease awareness among children and adults. Moreover, launch of new pediatric medical devices such as seizure monitors, wireless pulse oximeters, and heart monitors in the region is expected to drive the market during the forecast period. Asia Pacific is an untapped market as compared to the developed regions. Hence, the region presents better opportunities in the pediatric medical devices market. China and India are the most populous countries in the world and have the largest pediatric population, with high number of cancer and infectious disease patients. Demand for pediatric medical devices in countries such as Malaysia, Indonesia, Singapore, and India is also increasing rapidly. Considering the low health care spending, market players entering Asia Pacific will offer reasonably priced products to capture higher share.

Abbott Laboratories, Medtronic plc, and GE Healthcare to Lead Market

The report also provides profiles of leading players operating in the global pediatric medical devices market. These include Abbott Laboratories, Boston Scientific Corporation, Baxter International, Inc., Medtronic plc, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Koninklijke Philips N.V., and Stryker Corporation.

More Trending Reports by Transparency Market Research –

Multiple Sclerosis Drugs Market –

https://www.prnewswire.com/news-releases/consistent-efforts-to-find-effective-drugs-is-driving-growth-of-multiple-sclerosis-drugs-market-to-valuation-of-us-32-bn-by-2027-finds-tmr-301004337.html

Respiratory Antiviral Treatment Market –

https://www.biospace.com/article/respiratory-antiviral-treatment-market-trends-analysis-influenza-segment-to-experience-strong-growth/

[healthcareresearch010-blog]

Pediatric Medical Devices Market to Reach an Estimated Value of US$ 41,000 Mn by the End of 2026

Transparency Market Research (TMR) has published a new report titled, “Pediatric Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and others drive the global market. Moreover, surge in demand for self-care devices/solutions, increase in incidence of chronic and infectious diseases among pediatric population, and technological developments are expected to propel demand for pediatric medical devices used to treat chronic conditions.

Prevalence of chronic health disorders is rising among children. A report published by the Pediatric Academic Societies in 2016 stated that these chronic conditions are most common among children who live in or near poverty. The report found substantial increase in attention deficit hyperactivity disorder (ADHD) and asthma among children living in poverty, as compared to their comfortable counterparts.

The global pediatric medical devices market has been segmented based on product and end-user. In terms of product, the global market has been categorized into in vitro diagnostic (IVD) devices, cardiology devices diagnostic imaging devices, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine, and home-use medical devices. In vitro diagnostic (IVD) devices are available in the form of reagents, kits, instruments, equipment, apparatuses, or systems, used either alone or in combination with other diagnostic tools to gain critical information for health and drug/therapy monitoring. In vitro diagnostics deliver valuable information about the pathological and/or physiological state of the body and, therefore, are essential to make well-informed medical decisions.

Cardiology devices are used to diagnose and monitor patients suffering from cardiovascular diseases, primarily to identify the seriousness of the condition and effect of treatment on a patient. Diagnostic imaging devices are used in the diagnosis of various critical diseases and disorders of vital organs such as liver, lungs, heart, and brain. Usage of diagnostic imaging techniques such as MRI, X-ray, and CT scan has increased in the last two decades. These imaging technologies are painless and offer rapid diagnosis, making them a popular option for patients and doctors alike. Anesthesia devices comprise anesthesia workstations, anesthesia ventilators, anesthesia monitors, and anesthesia delivery machines. Respiratory care devices are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation, and aid mucus removal from bronchi during respiratory therapy.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46284

Moreover, neonates admitted to neonatal intensive care units are premature, have low birth weight, or suffer from a medical condition that requires special care. Newborns with medical conditions such as infections, birth defects, or heart problems are also cared for in the NICU. Neonatal intensive care units comprise advanced technology and trained health care professionals who provide personal medical attention to the admitted newborn babies.

Monitoring devices are used for continuous monitoring of health status of pediatrics by communication techniques, wearable detecting devices, and a small energy consumption microchip with high efficiency data handling algorithms. Telemedicine includes teleconsultation, telemonitoring, tele-education, teletraining, telecare, and telesurgery. It involves consultation services offered by experienced individuals covering various domains and activities to help, advice, and assist in the overall progress of an activity/initiative. A home-use medical device is proposed for users in any environment outside of a professional health care facility. This comprises devices proposed for use in both professional health care facilities and homes.

The report offers detailed segmentation of the global pediatric medical devices market based on products and end-user. In terms of product, the neonatal ICU devices segment is estimated to account for major share of the market from 2018 to 2026. The segment is likely to account for the major share of the market by 2026. It is also expected to grow at a rapid pace during the forecast period. Growth of the segment is attributed to increase in number of premature births across the globe.

North America accounts for the leading share of the global pediatric medical devices market, primarily due to its large patient population and increase in disease awareness among children and adults. Moreover, launch of new pediatric medical devices such as seizure monitors, wireless pulse oximeters, and heart monitors in the region is expected to drive the market during the forecast period. Asia Pacific is an untapped market as compared to the developed regions. Hence, the region presents better opportunities in the pediatric medical devices market. China and India are the most populous countries in the world and have the largest pediatric population, with high number of cancer and infectious disease patients. Demand for pediatric medical devices in countries such as Malaysia, Indonesia, Singapore, and India is also increasing rapidly. Considering the low health care spending, market players entering Asia Pacific will offer reasonably priced products to capture higher share.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46284

The report also provides profiles of leading players operating in the global pediatric medical devices market. These include Abbott Laboratories, Boston Scientific Corporation, Baxter International, Inc., Medtronic plc, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Koninklijke Philips N.V., and Stryker Corporation.

[coolluminaryland-blog1]

Pediatric Medical Devices Market is Expected To Demonstrate a CAGR of 8.0% by 2026

Transparency Market Research (TMR) has published a new report titled, “Pediatric Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and others drive the global market. Moreover, surge in demand for self-care devices/solutions, increase in incidence of chronic and infectious diseases among pediatric population, and technological developments are expected to propel demand for pediatric medical devices used to treat chronic conditions.

Rise in Chronic Conditions to Augment Market

Prevalence of chronic health disorders is rising among children. A report published by the Pediatric Academic Societies in 2016 stated that these chronic conditions are most common among children who live in or near poverty. The report found substantial increase in attention deficit hyperactivity disorder (ADHD) and asthma among children living in poverty, as compared to their comfortable counterparts.

The global pediatric medical devices market has been segmented based on product and end-user. In terms of product, the global market has been categorized into in vitro diagnostic (IVD) devices, cardiology devices diagnostic imaging devices, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine, and home-use medical devices. In vitro diagnostic (IVD) devices are available in the form of reagents, kits, instruments, equipment, apparatuses, or systems, used either alone or in combination with other diagnostic tools to gain critical information for health and drug/therapy monitoring. In vitro diagnostics deliver valuable information about the pathological and/or physiological state of the body and, therefore, are essential to make well-informed medical decisions. Cardiology devices are used to diagnose and monitor patients suffering from cardiovascular diseases, primarily to identify the seriousness of the condition and effect of treatment on a patient. Diagnostic imaging devices are used in the diagnosis of various critical diseases and disorders of vital organs such as liver, lungs, heart, and brain. Usage of diagnostic imaging techniques such as MRI, X-ray, and CT scan has increased in the last two decades. These imaging technologies are painless and offer rapid diagnosis, making them a popular option for patients and doctors alike. Anesthesia devices comprise anesthesia workstations, anesthesia ventilators, anesthesia monitors, and anesthesia delivery machines. Respiratory care devices are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation, and aid mucus removal from bronchi during respiratory therapy.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46284

Moreover, neonates admitted to neonatal intensive care units are premature, have low birth weight, or suffer from a medical condition that requires special care. Newborns with medical conditions such as infections, birth defects, or heart problems are also cared for in the NICU. Neonatal intensive care units comprise advanced technology and trained health care professionals who provide personal medical attention to the admitted newborn babies. Monitoring devices are used for continuous monitoring of health status of pediatrics by communication techniques, wearable detecting devices, and a small energy consumption microchip with high efficiency data handling algorithms. Telemedicine includes teleconsultation, telemonitoring, tele-education, teletraining, telecare, and telesurgery. It involves consultation services offered by experienced individuals covering various domains and activities to help, advice, and assist in the overall progress of an activity/initiative. A home-use medical device is proposed for users in any environment outside of a professional health care facility. This comprises devices proposed for use in both professional health care facilities and homes.

Neonatal ICU Devices to Account for Major Market Share

The report offers detailed segmentation of the global pediatric medical devices market based on products and end-user. In terms of product, the neonatal ICU devices segment is estimated to account for major share of the market from 2018 to 2026. The segment is likely to account for the major share of the market by 2026. It is also expected to grow at a rapid pace during the forecast period. Growth of the segment is attributed to increase in number of premature births across the globe.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46284

North America Dominated the Market

North America accounts for the leading share of the global pediatric medical devices market, primarily due to its large patient population and increase in disease awareness among children and adults. Moreover, launch of new pediatric medical devices such as seizure monitors, wireless pulse oximeters, and heart monitors in the region is expected to drive the market during the forecast period. Asia Pacific is an untapped market as compared to the developed regions. Hence, the region presents better opportunities in the pediatric medical devices market. China and India are the most populous countries in the world and have the largest pediatric population, with high number of cancer and infectious disease patients. Demand for pediatric medical devices in countries such as Malaysia, Indonesia, Singapore, and India is also increasing rapidly. Considering the low health care spending, market players entering Asia Pacific will offer reasonably priced products to capture higher share.

Abbott Laboratories, Medtronic plc, and GE Healthcare to Lead Market

The report also provides profiles of leading players operating in the global pediatric medical devices market. These include Abbott Laboratories, Boston Scientific Corporation, Baxter International, Inc., Medtronic plc, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Koninklijke Philips N.V., and Stryker Corporation.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

[digimarketresearch]

Induced Pluripotent Stem Cells Market Size, Share, Trends, Global Demand, Growth and Opportunity Analysis

"Induced Pluripotent Stem Cells (iPSCs) Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The large scale Induced Pluripotent Stem Cells (iPSCs) Market report is prepared by taking into account the market type, organization volume, accessibility on-premises, end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. Extremely talented pool has invested a lot of time for doing market research analysis and to generate this market report. Induced Pluripotent Stem Cells (iPSCs) Market report is sure to help businesses for the long lasting accomplishments in terms of better decision making, revenue generation, prioritizing market goals and profitable business.

Access Full 350 Pages PDF Report @

The global induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,081.08 million by 2029. Increasing research activities over stem cell therapies act as driver for the induced pluripotent stem cells (iPSCs) market growth.

Key Coverage in the Induced Pluripotent Stem Cells (iPSCs) Market Report:

Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the Induced Pluripotent Stem Cells (iPSCs) industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Induced Pluripotent Stem Cells (iPSCs) Market Landscape

Part 04: Global Induced Pluripotent Stem Cells (iPSCs) Market Sizing

Part 05: Global Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The major companies which are dealing in the induced pluripotent stem cells (iPSCs) are Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte,  Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia, Inc. and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Dupuytrens Disease Market

Mitogen Activated Protein Kinase Mapk Inhibitors Therapeutics Market

Neonatal Seizures Drugs Market

Chikungunya Treatment Market

Sickle Cell Disease Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com"

[coolluminaryland-blog1]

Pediatric Medical Devices Market to Expand at a Modest CAGR of 8.0% From 2018 to 2026

Transparency Market Research (TMR) has published a new report titled, “Pediatric Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and others drive the global market. Moreover, surge in demand for self-care devices/solutions, increase in incidence of chronic and infectious diseases among pediatric population, and technological developments are expected to propel demand for pediatric medical devices used to treat chronic conditions.

Rise in Chronic Conditions to Augment Market

Prevalence of chronic health disorders is rising among children. A report published by the Pediatric Academic Societies in 2016 stated that these chronic conditions are most common among children who live in or near poverty. The report found substantial increase in attention deficit hyperactivity disorder (ADHD) and asthma among children living in poverty, as compared to their comfortable counterparts.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46284

The global pediatric medical devices market has been segmented based on product and end-user. In terms of product, the global market has been categorized into in vitro diagnostic (IVD) devices, cardiology devices diagnostic imaging devices, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine, and home-use medical devices. In vitro diagnostic (IVD) devices are available in the form of reagents, kits, instruments, equipment, apparatuses, or systems, used either alone or in combination with other diagnostic tools to gain critical information for health and drug/therapy monitoring. In vitro diagnostics deliver valuable information about the pathological and/or physiological state of the body and, therefore, are essential to make well-informed medical decisions. Cardiology devices are used to diagnose and monitor patients suffering from cardiovascular diseases, primarily to identify the seriousness of the condition and effect of treatment on a patient.

Diagnostic imaging devices are used in the diagnosis of various critical diseases and disorders of vital organs such as liver, lungs, heart, and brain. Usage of diagnostic imaging techniques such as MRI, X-ray, and CT scan has increased in the last two decades. These imaging technologies are painless and offer rapid diagnosis, making them a popular option for patients and doctors alike. Anesthesia devices comprise anesthesia workstations, anesthesia ventilators, anesthesia monitors, and anesthesia delivery machines. Respiratory care devices are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation, and aid mucus removal from bronchi during respiratory therapy.

Request Report For Discount: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=46284

Moreover, neonates admitted to neonatal intensive care units are premature, have low birth weight, or suffer from a medical condition that requires special care. Newborns with medical conditions such as infections, birth defects, or heart problems are also cared for in the NICU. Neonatal intensive care units comprise advanced technology and trained health care professionals who provide personal medical attention to the admitted newborn babies. Monitoring devices are used for continuous monitoring of health status of pediatrics by communication techniques, wearable detecting devices, and a small energy consumption microchip with high efficiency data handling algorithms. Telemedicine includes teleconsultation, telemonitoring, tele-education, teletraining, telecare, and telesurgery. It involves consultation services offered by experienced individuals covering various domains and activities to help, advice, and assist in the overall progress of an activity/initiative. A home-use medical device is proposed for users in any environment outside of a professional health care facility. This comprises devices proposed for use in both professional health care facilities and homes.

Neonatal ICU Devices to Account for Major Market Share

The report offers detailed segmentation of the global pediatric medical devices market based on products and end-user. In terms of product, the neonatal ICU devices segment is estimated to account for major share of the market from 2018 to 2026. The segment is likely to account for the major share of the market by 2026. It is also expected to grow at a rapid pace during the forecast period. Growth of the segment is attributed to increase in number of premature births across the globe.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=46284

North America Dominated the Market

North America accounts for the leading share of the global pediatric medical devices market, primarily due to its large patient population and increase in disease awareness among children and adults. Moreover, launch of new pediatric medical devices such as seizure monitors, wireless pulse oximeters, and heart monitors in the region is expected to drive the market during the forecast period. Asia Pacific is an untapped market as compared to the developed regions. Hence, the region presents better opportunities in the pediatric medical devices market. China and India are the most populous countries in the world and have the largest pediatric population, with high number of cancer and infectious disease patients. Demand for pediatric medical devices in countries such as Malaysia, Indonesia, Singapore, and India is also increasing rapidly. Considering the low health care spending, market players entering Asia Pacific will offer reasonably priced products to capture higher share.

Abbott Laboratories, Medtronic plc, and GE Healthcare to Lead Market

The report also provides profiles of leading players operating in the global pediatric medical devices market. These include Abbott Laboratories, Boston Scientific Corporation, Baxter International, Inc., Medtronic plc, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Koninklijke Philips N.V., and Stryker Corporation.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/